Marimed (MRMD) Depreciation and Depletion (2016 - 2026)

Marimed (MRMD) has 11 years of Depreciation and Depletion data on file, last reported at $2.2 million in Q1 2026.

• On a quarterly basis, Depreciation and Depletion rose 22.22% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $8.5 million, a 8.97% increase from a year earlier, with the FY2025 full-year figure at $8.1 million, up 2.53% from the prior year.
• Depreciation and Depletion for Q1 2026 stood at $2.2 million, up from $2.1 million in the prior quarter.
• Over the last five years, Depreciation and Depletion for MRMD reached as high as $2.2 million in Q4 2024 and fell as low as $700000.0 in Q1 2022.
• Historically, Depreciation and Depletion has averaged $1.6 million across 5 years, with a median of $1.8 million in 2024.
• Across the five-year window, Depreciation and Depletion jumped 90.0% in 2024 and fell 5.26% in 2025, its largest moves.
• Year by year, Depreciation and Depletion stood at $900000.0 in 2022, then surged by 88.89% to $1.7 million in 2023, then rose by 29.41% to $2.2 million in 2024, then dropped by 4.55% to $2.1 million in 2025, then advanced by 4.76% to $2.2 million in 2026.
• Per Business Quant data, the three most recent Depreciation and Depletion figures were $2.2 million in Q1 2026, $2.1 million in Q4 2025, and $2.1 million in Q3 2025.